EPS Diluted (TTM) Chart

Historical EPS Diluted (TTM) Data

View and export this data back to 2018. Start Trial.
Date Value
June 30, 2026 -1.849
March 31, 2026 -1.974
December 31, 2025 -1.817
September 30, 2025 -1.093
June 30, 2025 -0.6639
March 31, 2025 -0.1958
December 31, 2024 0.1247
September 30, 2024 -0.6012
June 30, 2024 -0.8903
March 31, 2024 -1.049
December 31, 2023 -1.300
September 30, 2023 -0.9683
June 30, 2023 -0.6227
March 31, 2023 -0.5055
December 31, 2022 1.286
September 30, 2022 0.9816
Date Value
June 30, 2022 0.4719
March 31, 2022 0.193
December 31, 2021 -1.760
September 30, 2021 -1.546
June 30, 2021 -4.080
March 31, 2021 -3.941
December 31, 2020 -3.649
September 30, 2020 -3.817
June 30, 2020 -0.8561
March 31, 2020 -0.6031
December 31, 2019 -0.5602
September 30, 2019 -0.3013
June 30, 2019 -0.218
March 31, 2019 -0.1026
December 31, 2018 0.00

EPS Diluted (TTM) Range, Past 5 Years

View EPS Diluted (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (TTM) Benchmarks

View EPS Diluted (TTM) Benchmarks
Start Trial
BioNTech SE -7.847
MediGene AG --
InflaRx NV -0.6484
Twist Bioscience Corp. -2.224
Prime Medicine, Inc. -1.086